Human embryonic stem cell lines created that avoid immune rejection

In a groundbreaking experiment published in Cloning & Stem Cells, scientists from International Stem Cell (ISC) Corp. derived four unique embryonic stem cell lines that open the door for the creation of therapeutic cells that will not provoke an immune reaction in large segments of the population. The stem cell lines are “HLA-homozygous,” meaning that they have a simple genetic profile in the critical areas of the DNA that code for immune rejection.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news117375221.html">Human embryonic stem cell lines created that avoid immune rejection</a></p> <p>In a groundbreaking experiment published in <i>Cloning & Stem Cells</i>, scientists from International Stem Cell (ISC) Corp. derived four unique embryonic stem cell lines that open the door for the creation of therapeutic cells that will not provoke an immune reaction in large segments of the population. The stem cell lines are “HLA-homozygous,” meaning that they have a simple genetic profile in the critical areas of the DNA that code for immune rejection.</p>